Similarly, promising results were also seen in pre-clinical trials in adult rats with streptozotocin-induced diabetes treated with the DNMT inhibitor procainamide, which significantly reduced the activity of DNMT in the pancreas and significantly increased fasting insulin levels [30]. The gene discussed is DNMT1; the disease is diabetes mellitus.